NO963143L - Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne - Google Patents
Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denneInfo
- Publication number
- NO963143L NO963143L NO963143A NO963143A NO963143L NO 963143 L NO963143 L NO 963143L NO 963143 A NO963143 A NO 963143A NO 963143 A NO963143 A NO 963143A NO 963143 L NO963143 L NO 963143L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- active substances
- colestipol
- carries
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oral legemiddelform med en bærer for surt virkestoff, hvorunder virkestoffet har minst en fri karboksylgruppe som er ionisk bundet til en polymer med tertiasre aminogrupper, er karakterisert ved at polymeren er colestipol hhv. colestipol- hydroklorid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4402379A DE4402379C2 (de) | 1994-01-27 | 1994-01-27 | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
PCT/EP1994/004082 WO1995020394A1 (de) | 1994-01-27 | 1994-12-08 | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO963143D0 NO963143D0 (no) | 1996-07-26 |
NO963143L true NO963143L (no) | 1996-09-24 |
Family
ID=6508812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO963143A NO963143L (no) | 1994-01-27 | 1996-07-26 | Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne |
Country Status (22)
Country | Link |
---|---|
US (1) | US5858344A (no) |
EP (1) | EP0741574B1 (no) |
JP (1) | JP3701971B2 (no) |
KR (1) | KR100439311B1 (no) |
AT (1) | ATE218371T1 (no) |
AU (1) | AU697353B2 (no) |
CA (1) | CA2182417C (no) |
CZ (1) | CZ291006B6 (no) |
DE (2) | DE4402379C2 (no) |
DK (1) | DK0741574T3 (no) |
ES (1) | ES2177622T3 (no) |
FI (1) | FI116880B (no) |
HU (1) | HU223317B1 (no) |
IL (1) | IL112435A (no) |
MY (1) | MY113340A (no) |
NO (1) | NO963143L (no) |
NZ (1) | NZ277777A (no) |
PL (1) | PL315619A1 (no) |
PT (1) | PT741574E (no) |
SK (1) | SK97296A3 (no) |
WO (1) | WO1995020394A1 (no) |
ZA (1) | ZA95638B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403367B1 (en) * | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
DE19615820A1 (de) * | 1996-04-06 | 1997-10-09 | Holger Specht | Zahnpflegemittel und Verfahren zu seiner Herstellung |
US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
BRPI0718579B1 (pt) | 2006-11-07 | 2016-10-18 | Procter & Gamble | composição ingerível, extrudada, na forma de uma goma de mascar compreendendo um componente de fibras |
US7767248B2 (en) * | 2007-02-02 | 2010-08-03 | Overly Iii Harry J | Soft chew confectionary with high fiber and sugar content and method for making same |
WO2022259848A1 (ja) | 2021-06-07 | 2022-12-15 | 国立大学法人筑波大学 | 高分子化バルプロ酸及びその使用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ191762A (en) * | 1978-10-19 | 1982-09-14 | Merck & Co Inc | Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
EP0087864B1 (en) * | 1982-03-01 | 1986-10-15 | Efamol Limited | Pharmaceutical composition |
US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
EP0409432A3 (en) * | 1989-07-20 | 1991-12-11 | Warner-Lambert Company | Confectionery delivery system |
CA2040865C (en) * | 1990-05-15 | 2002-07-23 | James L. Bergey | Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
-
1994
- 1994-01-27 DE DE4402379A patent/DE4402379C2/de not_active Expired - Fee Related
- 1994-12-08 DK DK95904434T patent/DK0741574T3/da active
- 1994-12-08 NZ NZ277777A patent/NZ277777A/en not_active IP Right Cessation
- 1994-12-08 PL PL94315619A patent/PL315619A1/xx unknown
- 1994-12-08 US US08/693,101 patent/US5858344A/en not_active Expired - Lifetime
- 1994-12-08 AU AU13127/95A patent/AU697353B2/en not_active Ceased
- 1994-12-08 ES ES95904434T patent/ES2177622T3/es not_active Expired - Lifetime
- 1994-12-08 CA CA002182417A patent/CA2182417C/en not_active Expired - Fee Related
- 1994-12-08 HU HU9602041A patent/HU223317B1/hu not_active IP Right Cessation
- 1994-12-08 EP EP95904434A patent/EP0741574B1/de not_active Expired - Lifetime
- 1994-12-08 DE DE59410133T patent/DE59410133D1/de not_active Expired - Lifetime
- 1994-12-08 SK SK972-96A patent/SK97296A3/sk unknown
- 1994-12-08 KR KR1019960704025A patent/KR100439311B1/ko not_active IP Right Cessation
- 1994-12-08 CZ CZ19962213A patent/CZ291006B6/cs not_active IP Right Cessation
- 1994-12-08 AT AT95904434T patent/ATE218371T1/de active
- 1994-12-08 PT PT95904434T patent/PT741574E/pt unknown
- 1994-12-08 WO PCT/EP1994/004082 patent/WO1995020394A1/de active IP Right Grant
- 1994-12-08 JP JP51984995A patent/JP3701971B2/ja not_active Expired - Fee Related
-
1995
- 1995-01-24 IL IL11243595A patent/IL112435A/en not_active IP Right Cessation
- 1995-01-26 MY MYPI95000183A patent/MY113340A/en unknown
- 1995-01-26 ZA ZA95638A patent/ZA95638B/xx unknown
-
1996
- 1996-07-26 FI FI962985A patent/FI116880B/fi not_active IP Right Cessation
- 1996-07-26 NO NO963143A patent/NO963143L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2182417C (en) | 2007-04-17 |
ES2177622T3 (es) | 2002-12-16 |
EP0741574A1 (de) | 1996-11-13 |
FI116880B (fi) | 2006-03-31 |
JP3701971B2 (ja) | 2005-10-05 |
HU9602041D0 (en) | 1996-09-30 |
FI962985A (fi) | 1996-07-26 |
WO1995020394A1 (de) | 1995-08-03 |
IL112435A0 (en) | 1995-03-30 |
NZ277777A (en) | 1997-01-29 |
ZA95638B (en) | 1995-10-25 |
EP0741574B1 (de) | 2002-06-05 |
DE4402379A1 (de) | 1995-08-03 |
KR100439311B1 (ko) | 2005-08-17 |
FI962985A0 (fi) | 1996-07-26 |
HU223317B1 (hu) | 2004-05-28 |
DE59410133D1 (de) | 2002-07-11 |
NO963143D0 (no) | 1996-07-26 |
DK0741574T3 (da) | 2002-09-23 |
KR970700505A (ko) | 1997-02-12 |
PL315619A1 (en) | 1996-11-25 |
ATE218371T1 (de) | 2002-06-15 |
SK97296A3 (en) | 1997-04-09 |
JPH09511488A (ja) | 1997-11-18 |
HUT74434A (en) | 1996-12-30 |
AU1312795A (en) | 1995-08-15 |
US5858344A (en) | 1999-01-12 |
CA2182417A1 (en) | 1995-08-03 |
CZ291006B6 (cs) | 2002-11-13 |
CZ221396A3 (en) | 1997-01-15 |
PT741574E (pt) | 2002-11-29 |
DE4402379C2 (de) | 1997-09-25 |
AU697353B2 (en) | 1998-10-01 |
MY113340A (en) | 2002-01-31 |
IL112435A (en) | 1999-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9600572D0 (en) | Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form | |
DK0706378T3 (da) | Ny farmaceutisk formulering. | |
AR003415A1 (es) | Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma. | |
ES2133785T3 (es) | Inhibidores de metaloproteinasas. | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
MX9600857A (es) | Forma de dosificacion i en tabletas, con unidades multiples. | |
MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
DE59609508D1 (de) | Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln | |
NO963143D0 (no) | Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne | |
DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
AR002191A1 (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion | |
DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
PT1231908E (pt) | Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia | |
ATE85218T1 (de) | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid. | |
JO1881B1 (en) | Formula II for multi unit disc calibration | |
DE59403326D1 (de) | Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs |